• Thumbnail for Experimental models of Alzheimer's disease
    Experimental models of Alzheimer's disease are organism or cellular models used in research to investigate biological questions about Alzheimer's disease...
    41 KB (3,543 words) - 11:13, 9 March 2024
  • progression of AD. Much of the known biochemistry of Alzheimer's disease has been deciphered through research using experimental models of Alzheimer's disease. At...
    65 KB (7,761 words) - 09:06, 10 September 2024
  • Thumbnail for Alzheimer's disease
    Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, and is the cause of 60–70% of cases of dementia...
    183 KB (19,440 words) - 12:49, 30 September 2024
  • Thumbnail for Model organism
    nematode worm), experimental models, and genomic parsimony models, investigating pivotal position in the evolutionary tree. Historically, model organisms include...
    89 KB (9,348 words) - 16:50, 28 August 2024
  • Thumbnail for Amyloid plaques
    with the complete neuropathology of Alzheimer's disease. Both human samples and experimental models of Alzheimer's disease have been used to study the biochemical...
    31 KB (3,370 words) - 18:46, 11 August 2024
  • Thumbnail for Chronic traumatic encephalopathy
    neuropathological appearance of CTE is distinguished from other tauopathies, such as Alzheimer's disease. The four clinical stages of observable CTE disability...
    63 KB (6,656 words) - 04:20, 24 September 2024
  • Thumbnail for Proteinopathy
    mad cow disease) and other prion diseases, Alzheimer's disease, Parkinson's disease, amyloidosis, multiple system atrophy, and a wide range of other disorders...
    62 KB (4,598 words) - 21:08, 10 September 2024
  • Thumbnail for Fosgonimeton
    toxicity in preclinical models of Alzheimer's disease". Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 21 (4):...
    3 KB (111 words) - 22:21, 13 September 2024
  • The biomarkers of Alzheimer's disease are neurochemical indicators used to assess the risk or presence of the disease. The biomarkers can be used to diagnose...
    13 KB (1,704 words) - 11:44, 4 April 2024
  • Thumbnail for Simufilam
    Simufilam (category Experimental drugs for Alzheimer's disease)
    Simufilam (PTI-125) is an experimental medication for the treatment of Alzheimer's disease. It is being developed by the American pharmaceutical firm Cassava...
    29 KB (2,526 words) - 11:32, 20 August 2024